SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-016431
Filing Date
2021-08-10
Accepted
2021-08-10 16:55:28
Documents
52
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgls-20210630.htm   iXBRL 10-Q 1521454
2 EX-5.1 exhibit51-opinionfor2021at.htm EX-5.1 15370
3 EX-31.1 ex-311x20210630.htm EX-31.1 9813
4 EX-31.2 ex-312x20210630.htm EX-31.2 9790
5 EX-32.1 ex-321x20210630.htm EX-32.1 9679
11 image_1.jpg GRAPHIC 8359
  Complete submission text file 0001628280-21-016431.txt   5945162

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20210630.xsd EX-101.SCH 36896
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20210630_cal.xml EX-101.CAL 52048
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20210630_def.xml EX-101.DEF 215883
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20210630_lab.xml EX-101.LAB 504212
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20210630_pre.xml EX-101.PRE 313676
12 EXTRACTED XBRL INSTANCE DOCUMENT rgls-20210630_htm.xml XML 906640
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 211160688
SIC: 2834 Pharmaceutical Preparations